Literature DB >> 14508054

Pancytopenia in a patient with scleroderma treated with infliximab.

Y Menon, E Cucurull, L R Espinoza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508054     DOI: 10.1093/rheumatology/keg341

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

1.  Infliximab and serious hematologic events.

Authors:  Cynthia Phelan; Eric Wooltorton
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

Review 2.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

3.  Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges.

Authors:  E Montané; M Sallés; A Barriocanal; E Riera; J Costa; X Tena
Journal:  Clin Rheumatol       Date:  2006-10-10       Impact factor: 2.980

4.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.

Authors:  Wanling Sun; Zhijie Wu; Zenghua Lin; Maile Hollinger; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Blood       Date:  2018-10-25       Impact factor: 22.113

5.  Current Perspectives on the Role of TNF in Hematopoiesis Using Mice With Humanization of TNF/LT System.

Authors:  Violetta S Gogoleva; Kamar-Sulu N Atretkhany; Arina P Dygay; Taisiya R Yurakova; Marina S Drutskaya; Sergei A Nedospasov
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 6.  Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.

Authors:  Natasha Kozak; Joshua Friedman; Ami Schattner
Journal:  Drugs R D       Date:  2014-06

Review 7.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.